Combination Chemotherapy in Treating Patients With Sarcoma
Completed · Early Phase 1
Conditions studied: Ovarian Cancer, Sarcoma
In brief
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This clinical trial is studying how well combination chemotherapy works in treating patients with sarcoma.
Key facts
- Study ID
- NCT00662233
- Run by
- Mayo Clinic
- People needed
- 28
- Starts
- 1991-10-01
- Expected to finish
- 2013-10-21
- Last updated by the study team
- 2018-10-09
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.